CIDP

Divyanshu (Div) Dubey, M.B.B.S., describes Mayo Clinic Laboratories' new diagnostic test for CIDP, or chronic inflammatory demyelinating polyneuropathy. The new test detects two antibodies — NF155 and CNTN1 — to enhance diagnosis and guide treatment decisions. Often misdiagnosed, CIDP is treatable if detected early.

By Barbara J. Toman • August 23, 2022

Sophisticated laboratory testing solved a medical riddle and finally got Jori Pearson back on his feet, doing what he loves.

By Barbara J. Toman • April 4, 2022